Filing metadata

Accession number
0001127602-20-014554
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 27, 2020
Reporting period
Apr 02, 2020
Description
Initial ownership

Explore SEC Filings Hub